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Surveillance data suggests that use of ecstasy in the U.S. is predominantly among
white adolescent and young adults. To investigate ecstasy use among substance users in
New York City we added questions to ongoing efforts to recruit heroin and cocaine users.
Of 715 participants recruited, 58.3% were injection dug users (IDUs). The median age
was 32 (range 17–64), 76.4% were male, 49.0% were currently homeless, 62.4% were
Hispanic, 27.3% were black, and 34.5% were born outside the United States. Overall,
23.4% used ecstasy in their lifetime and 11.9% had used in the last-6 months. In mul-
tivariate logistic regression, correlates of lifetime ecstasy use included younger age,
being born in the U.S., and current homelessness. We observed a significant interaction
between injection drug use and race where, compared to black non-IDUs, Hispanic
non-IDUs, and white IDUs were significantly more likely to have a history of lifetime
ecstasy use while black IDUs were significantly less likely. These findings are limited
to persons who use other drugs, but suggest that further investigation of ecstasy use in
minority populations is warranted.
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Introduction
Club drugs have been a growing concern in the United States since the 1980s. Although
a number of psychoactive agents have been referred to as “club drugs,” the most common
substances encompassed by the term are: ecstasy (3,4-methylenedioxymethamphetamine
or MDMA), GHB (gamma-hydroxybutyrate), ketamine, LSD (lysergic acid diethylamide),
methamphetamines, PCP (phencyclidine), and Rohypnol©R (flunitrazepam). Currently avail-
able data suggest that ecstasy use in the United States is most common (Arria et al., 2002;
Yacoubian, 2002). Recently, national surveillance data have suggested that ecstasy use is
declining among adolescents (Johnston, O’Malley, and Bachman, 2002). However, these
observations arise from studies conducted among predominantly white populations. With
the exception of the national surveillance studies (e.g., Monitoring the Future Study, Na-
tional Household Survey on Drug Abuse), most domestic studies have been conducted
among rave or circuit party attendees (Arria et al., 2002; Colfax et al., 2001; Mansergh
et al., 2001; Mattison et al., 2001), and men who have sex with men (Colfax et al., 2001;
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Mansergh et al., 2001; Mattison et al., 2001; Klitzman, Pope, and Hudson, 2000), most of
whom are white.
There is emerging evidence that the club drug economy may be changing. Recent
reports have documented the movement of club drugs from clubs and raves to the streets. The
National Institute on Drug Abuse’s Community Epidemiology Working Group has reported
that ecstasy was moving from the clubs to the street in several cities, including Baltimore
and New York (Community Epidemiology Work Group, 2001). In light of these changes in
drug use availability and the paucity of data available among minorities, we investigated the
use of ecstasy among minority substance users in New York City (N.Y.C.). To investigate
whether or not to conduct major efforts to estimate ecstasy use in minority communities,
we chose to start with a survey of use within an ongoing project that involves recruitment of
injectors as well as noninjectors of heroin or cocaine within two minority communities. This
sampling was not considered representative of the respective communities but was meant
to provide an indication of the presence of ecstasy that may then warrant closer attention.
Method
Research Sample
Between October 2002 and September 2003, we interviewed substance users participating
in three ongoing observational studies in N.Y.C. Eligibility for the parent studies included
age, ≥15 years old and recent (past 2 months) use of heroin, crack, or cocaine more than
monthly. Recruitment involved targeted sampling with street outreach techniques, and data
collection was conducted at two stationary storefronts in Central Harlem (Manhattan) and
the South Bronx and a recreational vehicle that parked in Brooklyn, the Lower East Side
of Manhattan, and Queens, all in N.Y.C. Recruitment methods used in these studies have
been described in more detail elsewhere (Diaz et al., 2001a; Diaz et al., 2001b). This study
was approved by the Institutional Review Board at the New York Academy of Medicine.
Data Collection
After providing informed consent, participants completed an interviewer-administered
questionnaire that elicited information on demographic characteristics and drug use (i.e.,
type, frequency, duration). A supplemental questionnaire was added to ongoing studies to
elicit detailed information on club drug use. Participants were reimbursed $20 for partici-
pation in the study.
Statistical Analysis
Bivariate analyses were conducted to assess the relation between demographic and club
drug use variables by race using chi-square statistics for categorical variables and ANOVA
for continuous variables. Covariates that were significantly associated with use of ecstasy in
bivariate analyses (p < 0.2) were entered into a multivariate logistic model. Variables were
retained in the final model if they were significant at the p = 0.10 level. Potential interactions
were examined, including race and country of birth and race and injection drug use. All
analyses were conducted using Intercooled STATA 7 (Stata Corp., College Station, Texas).
Results
Between October 2002 and September 2003, we recruited 715 substance users. Among
these, 546 (76.4%) were male and 169 (23.6%) were female. Hispanics were the
Ecstasy Use Among Hispanic and Black Substance Users 1401
Table 1
Selected demographic characteristics and ecstasy use among 715 substance users in
New York City, October 2002–March 2003
Hispanic Black White
Total N(%) N(%) N(%)
N = 715 N = 446 N = 195 N = 74 p-value
Gender
Male 546 (76.4) 363 (81.4) 140 (71.8) 43 (58.1) <0.001
Female 169 (23.6) 83 (18.6) 55 (28.2) 31 (41.9)
≤25-years old 179 (25.0) 129 (28.9) 28 (14.4) 22 (29.7) <0.001
U.S. born 468 (65.9) 231 (52.1) 176 (90.7) 61 (83.6) <0.001
Lived in New York <1 year 85 (11.9) 73 (16.4) 5 (2.6) 7 (9.5) <0.001
Currently homeless 350 (49.0) 218 (49.0) 91 (46.7) 41 (55.4) 0.441
Dropped out of school 492 (74.5) 354 (79.8) 137 (79.7) 39 (53.4) <0.001
High school diploma 325 (45.5) 168 (37.8) 108 (55.4) 49 (66.2) <0.001
or equivalent
Lifetime heroin use 690 (96.5) 440 (98.7) 177 (90.8) 73 (98.7) <0.001
Lifetime crack use 619 (86.6) 376 (84.3) 174 (89.2) 64 (93.2) 0.050
Lifetime cocaine use 695 (97.2) 433 (97.1) 188 (96.4) 74 (100.0) 0.272
Lifetime injection drug use 416 (58.3) 288 (64.7) 65 (33.3) 63 (85.1) <0.001
Lifetime ecstasy use 183 (25.6) 119 (26.7) 31 (15.9) 33 (44.6) <0.001
Mean age at first ecstasy 22.0 (6.7) 22.5 (6.5) 22.7 (8.1) 19.8 (5.7) 0.087
use (SD)
Current (last 6 months) 85 (11.9) 61 (13.7) 15 (7.7) 9 (12.2) 0.098
ecstasy use
predominant racial group (62.4%), followed by blacks (27.3%) and whites (10.3%). The
median age at enrollment was 32 (range 17–64). Half (49.0%) were currently homeless.
One-third (34.5%) had been born outside the United States, and 11.9% had lived in New
York City for less than a year. The proportion of the substance users that injected drugs was
58.3%. Overall, 25.6% reported using ecstasy in their lifetime and 11.9% had used it in the
last 6 months.
We assessed racial differences in demographic characteristics and ecstasy use (Table 1).
Hispanics were significantly more likely than blacks and whites to be male (81.4% vs. 71.8%
and 58.1%, respectively) and to have lived in New York City for less than a year (16.4% vs.
2.6% and 9.5%, respectively) and less likely to have been born in the U.S. (52.1% vs. 90.7%
and 83.6%, p < 0.001). Blacks tended to be older; whites were more likely to have a high
school diploma (or equivalent) and less likely to have dropped out of school. In terms of
substance use, whites were more likely than Hispanics and blacks to have a lifetime history
of both ecstasy use (44.6% vs. 26.7% and 15.9%, respectively) and crack use (93.2% vs.
84.3% and 89.2%, respectively) as well as to have a history of injection drug use (85.1%
vs. 64.7% and 33.3%, respectively). Compared to blacks, whites and Hispanics were more
likely to have used ecstasy in the last 6 months, although this association was not significant
(p = 0.098). Among the 85 people who had used ecstasy in the last 6 months, 47 (55.3%)
had used once a month or less, 13 (15.3%) had used 2 to 3 days a month, 11 (12.9%) had
used about once per week or 2 to 3 days per week, two (2.4%) had used 4 to 6 days per
week, and one (1.2%) had used everyday.
1402 Ompad et al.
Table 2
Multivariate logistic regression model for correlates of lifetime ecstasy use among 642
Hispanic and black substance users in New York City, October 2002–March 2003
Lifetime ecstasy use
Crude OR (95% CI) Adjusted OR (95% CI)
Age ≤25 4.49 (3.11, 6.48) 4.26 (2.87, 6.33)
U.S. born 1.21 (0.84, 1.74) 1.65 (1.08, 2.54)
Currently homeless 1.67 (1.19, 2.34) 1.56 (1.08, 2.27)
Race
Black 1.0 —
Hispanic 1.93 (1.24, 2.98) —
White 4.26 (2.34, 7.74) —
Injection drug use 0.73 (0.52, 1.02) —
Race by injection drug use interaction
Black noninjector — 1.0
Hispanic noninjector — 2.07 (1.16, 3.67)
White noninjector — 1.57 (0.41, 6.01)
Black injector — 0.24 (0.07, 0.82)
Hispanic injector — 1.13 (0.64, 1.97)
White injector — 3.08 (1.53 6.18)
aLast 6 months.
We next constructed a multivariate logistic regression model to examine correlates of
lifetime ecstasy use (Table 2). Ecstasy users were more likely to be 25 years old or younger
[Adjusted Odds Ratio (AOR) = 4.26, 95% Confidence Interval (CI): 2.87, 6.33], born in
the U.S. (AOR = 1.65, 95% CI: 1.08, 2.54), and currently homeless (AOR = 1.56, 95%
CI: 1.08, 2.27). We observed a significant interaction between injection drug use and race
where, compared to black noninjectors, Hispanic noninjectors and white injectors were
significantly more likely to have a history of lifetime ecstasy use (AOR = 2.07, 95% CI:
1.16, 3.67 and AOR = 3.08, 95% CI: 1.53, 6.18, respectively), while black injectors were
significantly less likely (AOR = 0.24, 95% CI: 0.07, 0.82). The Pearson χ2 goodness-of-fit
test for the estimated model indicated that we could not reject the model (p = 0.1457).
Finally, we constructed a multivariate logistic regression model to examine correlates
of recent ecstasy use (Table 3). Compared to blacks, Hispanics were significantly more
likely to have used ecstasy in the last 6 months (AOR = 2.13, 95% CI: 1.11, 4.09). Ecstasy
users were more likely to be under 25 years old (AOR = 4.66, 95% CI: 2.87, 7.55),
currently homeless (AOR = 1.60, 95% CI: 0.98, 2.61), but less likely to be an injection drug
user (AOR = 0.39, 95% CI: 0.34, 0.66). We did not observe any significant interactions.
The Pearson χ2 goodness-of-fit test for the estimated model indicated good model fit (p =
0.7620).
Discussion
To date, evidence of club drug use among minority populations, and ecstasy use in particular,
is sparse. What little evidence there is suggests that, in broader population contexts, Asians
were more likely and blacks were less likely than whites to have used ecstasy in the past
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Table 3
Multivariate logistic regression model for correlates of recenta ec-
stasy use among 642 Hispanic and black substance users in New
York City, October 2002–March 2003
Crude OR (95% CI) Adjusted OR (95% CI)
Age ≤25 5.24 (3.27, 8.39) 4.66 (2.87, 7.55)
Currently homeless 1.66 (1.04, 2.63) 1.60 (0.98, 2.61)
Race
Black 1.0 1.0
Hispanic 1.90 (1.05, 3.44) 2.13 (1.11, 4.09)
White 1.66 (0.69, 3.98) 2.06 (0.78, 5.43)
Injection drug use 0.51 (0.32, 0.80) 0.39 (0.34, 0.66)
aLast 6 months.
year (Boyd, McCaben, and d’Arcy, 2003). Data from the Monitoring the Future (MTF)
Study found that ecstasy users in the general population are overwhelmingly white, where
between 89 and 91% of 12-month ecstasy users were white (Yacoubian, Jr., 2002). While
at least 30% of these samples are non-white, they represent students attending high school
(Yacoubian, Jr., 2002) or college (Boyd, McCaben, and d’Arcy, 2003). In our study, whites
reported a higher prevalence of lifetime ecstasy use (44.6%). However, lifetime history
of ecstasy use was common among street-recruited Hispanic and black users of heroin,
cocaine, and crack in New York City (26.7% and 15.9%, respectively).
Caution is needed in interpreting data from this study, as our sample included persons
selected for using other illicit drugs. This data then should not be construed as generalizing
to minority communities in general. What the data suggest instead is that street-based
ecstasy use is present at least in some measure within a subset of illicit drug users from
predominantly minority communities. Much of the current knowledge of the epidemiology
of ecstasy use relies on surveillance studies like the MTF Study, which samples public and
private school students in the United States (Johnston, O’Malley, and Bachman, 2002). In
our sample, only 46.1% had finished high school (or equivalent), and 77.0% had dropped out
of school at least once. Whether minority ecstasy users are more likely to drop out of school
is unclear, and needs further examination. It is likely that persons like the participants in our
studies are overlooked by surveillance systems such as the MTF, suggesting that current
U.S. estimates of prevalence of club drug use, particularly among minorities, are low.
Congruent with previous studies (Johnston, O’Malley, and Bachman, 2002; Strote,
Lee, and Wechsler, 2002), we observed that ecstasy users were young. We observed a
significant interaction between injection drug use and race where Hispanic noninjectors
and white injectors were significantly more likely, and black injectors were significantly
less likely, to have a history of lifetime ecstasy use. We also found that being U.S.-born was
an independent correlate of lifetime ecstasy use, but did not observe an interaction between
race and country of birth. Previous studies have reported that individuals born in the U.S.,
and Hispanics in particular (Brindis et al., 1995), have higher rates of drug use as compared
non-U.S. born immigrants (Johnson, VanGeest, and Cho, 2002). Further investigation of
this finding will be necessary to understand the social environment and context of ecstasy
use among U.S. minorities.
We also found that current homelessness was associated with lifetime ecstasy use. This
relationship has not been reported previously. A possible explanation for this relationship
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could be that homeless people are more mobile through the city or the country, and therefore
have access to different drug markets. Such data are not available in this dataset, but would
be an area for additional research. Qualitative data would also further our understanding of
this finding.
While the sample studied here is not representative of all minorities or all minority drug
users, it does provide evidence for ecstasy use among young black and Hispanic heroin,
crack, and cocaine users that is higher than the previously reported prevalences of ecstasy
use among minorities. Anecdotal reports suggest that MDMA is being sold on the streets
of Harlem and the South Bronx, areas that are predominantly Hispanic and black. The
changing venues of club drug use and the evolving club drug trade are beginning to be
documented (Community Epidemiology Work Group, 2001). Our findings provide further
evidence for availability of club drugs outside their tradition venues.
The burden of “substance abuse” is already high among minority communities in the
United States (Galea et al., 2003; Buka, 2002; Harlow, 1990), and the precarious health
status of these communities could be further compromised by another “epidemic” of drug
use. Our findings highlight the need for further investigation of ecstasy use in minority
populations, to determine the extent of use and to understand the posited risk factors and
their dimensions, the necessary conditions for them to operate or not, as well as correlates
of use among minorities.
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RÉSUMÉ
Des données recueillies semblent indiquer que l’usage de l’Ecstasy dans les États-
Unis est prédominante parmi les adolescents et les jeunes adultés. Pour étudier l’usage
de l’Ecstasy à New York City nous avons ajouté des questions aux oeuvres en cours pour
recruter des comsommateurs de l’héroı̈ne et de la cocaı̈ne. Parmi les 715 participants, 58,3%
étaient consommateurs d’injections de drogues (IDUs). L’âge médiane était de de 32 ans
(de 17 à 64), 76,4% étaient mâles, 49.0% étaient sans abri, 62.4% étaient Hispaniques et
27.3% étaient Noirs. 34.5% n’étaient pas nés dans les États Unis.
En général, 23.4% ont consommé de l’Ecstasy une fois ou l’autre et 11.9% l’ont con-
sommée pendant les derniers six mois. Dans l’analyse de régression logistique multivariée,
la corrélation de l’usage de l’Ecstasy de toute une vie y compris les jeunes, étant né dans
les États Unis, et les sans abri courants. Nous avons observé une interaction considérable
entre la consommation de la drogue injectée et la race où, comparés aux non-IDUs Noirs,
non-IDUs Hispaniques et IDUs Blancs avaient considérablement une histoire de consom-
mation de drogue pendant toute la vie plus probable tandis que les IDUs Noirs en étaient
considérablement moins problables. Ces conclusions sont limités aux personnes qui con-
somment d’autres drogues mais elles indiquent qu’une investigation plus ample de la con-
sommation de l’Ecstasy dans la population minoritaire est justifiée.
RESUMEN
Los datos observados nos sugieren que el uso de la droga Éxtasis en los EE. UU. ocurre
predominantemente entre los adolescentes blancos y los adultos jóvenes. Para investigar el
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uso de Extasis entre los usuarios de drogas en la ciudad de Nueva York, añadimos preguntas a
las formuladas en nuestros esfuerzos actuales para reclutar usuarios de heroı́na y de cocaı́na
para un estudio. De los 715 participantes reclutados, 58.3% eran usuarios de drogas por
inyección. La mediana de edad era de 32 años, en un grupo que abarcaba desde los 17 a los
64 años; 76.4% eran varones; 49% eran desamparados; 62.4% eran hispanos, y 27.3% eran
negros. 34.5% nacieron fuera de los EE. UU. En conjunto, 23.4% de ellos habı́an consumido
Extasis en algún momento de sus vidas, y 11.9% la habı́an usado en los últimos 6 meses.
En regresión logı́stica multivariada, los correlatos de uso del Extasis incluyeron una
menor edad del usuario, el haber nacido en los EE.UU., y el encontrarse actualmente sin
hogar. Observamos una interacción significativa entre el uso de drogas inyectadas y la raza:
comparados con los negros no usuarios de drogas inyectadas, los hispanos no usuarios de
drogas inyectadas y los blancos usuarios se mostraban significativamente más tendientes
al consumo de Éxtasis a lo largo de su vida, en tanto que los negros usuarios de drogas
inyectadas aparecı́an como significativamente menos tendientes a ello.
Estas conclusiones se limitan a personas que consumen otras drogas, pero sugieren que
está justificado el realizar investigaciones adicionales sobre el uso de Extasis entre grupos
demográficos minoritarios.
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